Skip to content Credex Healthcare provides end-to-end oncology billing services tailored to cancer centers, specialty clinics, and hospital-based oncology networks. We cover chemotherapy and biologic infusion billing, with a focus on accurate CPT code assignments, stringent prior authorization protocols, and meticulous resolution of documentation standards for infusion and chemotherapy drug administration. Every claim is supported by comprehensive infusion records and is processed in strict accordance with the latest Medicare and commercial payer oncology billing regulations.
Credex Healthcare’s oncology insurance billing services handle the end-to-end revenue cycle, beginning with verification of chemotherapy treatment plans and ongoing management of infusion schedules. We ensure claims are submitted with the correct CPT codes and provide comprehensive denial management, payment posting, and reconciliation to optimize revenue health.
First-pass claim approval rate
Average oncology billing turnaround
Medicare, Medicaid & commercial networks
Chemotherapy documentation management
Credex Healthcare utilizes a specialized oncology billing workflow that incorporates rigorous verification of chemotherapy prior authorizations, CPT and J-code accuracy, and comprehensive clinical documentation review prior to claim submission. With how complex chemotherapy protocols are and the high cost of oncology drugs, billing errors can result in substantial financial and compliance exposure. Payers conduct detailed audits of administration coding and supporting documentation; any discrepancies in infusion codes CPT 96413 or 96415 may result in claim denials and heightened compliance scrutiny.
Our oncology billing services in the USA cover the following:
Chemotherapy administration claims are submitted using validated CPT codes: 96413 (initial hour), 96415 (additional hour), 96417 (intravenous push), and 96365 (initial non-chemotherapy infusion). All claims contain finalized infusion records, current treatment plans, and signed oncologist orders. After submission, we promptly address payer inquiries for full compliance.
Credex Healthcare provides an efficient workflow for provider enrollment for oncology practices and infusion centers across Medicare, Medicaid, and commercial payer networks. This includes maintaining active Medicare oncology provider numbers, overseeing Medicaid oncology program registrations, and ensuring the currency of all commercial carrier credentialing.
Denied oncology claims are reviewed within 48 hours of notification. We investigate rejections based on missing or incorrect CPT codes, expired certifications, incomplete documentation, or payer-specific mandates. Credex Healthcare conducts correction and reprocessing with all necessary supporting records, including for chemotherapy administration or J-code drug billing.
Our oncology billing specialists review each claim to ensure the correct use of chemotherapy infusion CPT codes (96413, 96415, 96417, 96365) and corresponding J-codes. Documentation is verified against administration records, dosages, and oncologist orders to avoid auditing red flags.
Revenue optimization includes chemotherapy scheduling, CPT and J-code charge capture, prior authorization tracking, infusion documentation validation, claim submission, payment posting, and monthly reporting. This approach gives administrators accurate revenue analytics for oncology procedures, services, and drug reimbursement.
Credex Healthcare, a dedicated oncology billing service provider, tracks updates from Medicare, Medicaid, and commercial payers affecting oncology and infusion billing. We maintain current expertise in coding, documentation, and compliance standards, including changes regarding CPT and J-code. Our foresight allows every claim to be fully substantiated, protecting your financial integrity and compliance at every level.
Medicare covers oncology care under Part A when a patient elects the oncology benefit, and two physicians certify a terminal prognosis of six months or less. We manage Medicare oncology billing across all MAC jurisdictions, applying the correct level-of-care codes, managing certification period renewals, and maintaining documentation standards that support each billed day.
While Medicaid programs from most states cover oncology care, chemotherapy drug billing, and prior authorization requirements differ. Our specialists track state-specific Medicaid regulations for chemotherapy infusions and J-code drug billing, ensuring that all prior authorizations are secured and that each claim complies with applicable billing protocols.
Commercial insurers and managed care organizations have specific requirements for chemotherapy infusion and drug billing. Billing protocols highly depend on each payer, ensuring accurate CPT and J-code assignments, complete documentation, and compliance with each plan’s authorization and billing criteria.
Hospital-based chemotherapy infusions and extended sessions are among the most complex aspects of oncology billing, requiring detailed clinical records and strong documentation. We cater to these high-acuity services, ensuring every claim meets payer requirements and is audit-ready, especially when using time-based CPT codes such as 96413 and 96415, as well as relevant J-codes.
Oncology infusion and chemotherapy claims are vulnerable to audit flags or denials due to missing or expired certifications, incomplete authorizations, billing without finalized infusion documentation, or inconsistent CPT and J-code entries. Credex Healthcare facilitates the entire documentation, coding, and authorization process prior to claim submission to ensure compliance and reduce the risk of denials.
Each oncology and infusion claim is validated against your active Medicare provider number, agency NPI, and state oncology license before submission. Missing or mismatched identifiers can cause immediate rejections or compliance audits, especially for chemotherapy and J-code billing.
We audit census and treatment records against all relevant chemotherapy and infusion CPT codes (96413, 96415, 96417, 96365) and J-codes, verifying that each code is supplemented by clinical documentation and accurately reflects the provided services.
Medicare requires oncologist certification for each benefit period: two initial 90-day periods, followed by unlimited 60-day cycles. We monitor certification status and prior authorizations, send renewal alerts, and flag any documentation gaps.
Accounts Receivable Follow-Up
We audit oncology A/Rs weekly, focusing on outstanding chemotherapy and drug claims. Denials, such as those due to CPT/J-code discrepancies or certification issues, are appealed with complete clinical documentation and in accordance with CMS criteria to expedite resolution and maximize reimbursement.
Oncology agencies are experiencing revenue losses and compliance risks due to ongoing documentation and coding deficiencies. Common denial points include billing without finalized infusion records, certification disputes, and missing or outdated prior authorizations. Credex Healthcare’s workflow includes real-time documentation and coding validation in daily census review to strategically prevent denials and maintain compliance.
Comprehensive oncology insurance billing includes census and treatment reconciliation, charge capture for each chemotherapy and infusion service, and electronic claim submission to government and commercial payers for every patient during each billing cycle.
Our specialists ensure accurate CPT and J-code assignments for chemotherapy infusion, including all required documentation. This reduces denials due to billing documentation deficiencies.
Denial Management & Appeals
Denial management for oncology claims covers level-of-care disputes, certification-period documentation corrections, election-statement gaps, and clinical visit documentation deficiencies. All appeals are supplemented by clinical records and the Medicare oncology benefit policy that reverses the denial.
Our A/R reporting provides comprehensive analytics by chemotherapy and infusion procedure, J-code drug reimbursement, payer mix, prior authorization compliance, denial trends by CPT/J-code error, and billing turnaround time.
Years of Oncology Billing Expertise
Group Enrollment & Credentialing Success
Claim Compliance Rate Across Various Insurers
Support Available for Oncology Billing Needs
Customized Oncology Revenue Cycle Solutions
Executive Director
Kim
“Our Medicare partner flagged infusion billing errors on 22 patients over a specific quarter. The core issue was that our clinical infusion documentation and billing systems were not fully reconciled. Claims were being submitted before the infusion records were finalized, and drug administration details were available in the chart. Credex implemented a daily reconciliation step to ensure that all chemotherapy administration records and J-code drug documentation are finalized in the system before any claim is submitted. Since then, we have had no further findings from the medical review.”
MD
Tristan
“Oncologist certification and prior authorization tracking were manual processes before Credex, resulting in lapses every few months because the renewal timelines for chemotherapy and infusion authorizations weren’t monitored across our large census. Each lapse created a denied-billing period and a compliance risk. Credex automated our certification and prior authorization calendar, sending alerts ahead of each renewal, and tracking all infusion and chemotherapy authorizations separately.”
Revenue Cycle Administrator
Tonya
“Our four oncology programs are situated across 3 states, and Medicaid billing rules vary across states. Our previous billing company was applying one state’s rules across all our programs, and our Medicaid denials were recurring in the second state, which nobody could explain. Credex separated the billing by state program, applied the correct rules for each, and the Medicaid denial rate in the problem state dropped from 25% to under 6% in the first half of the second quarter.”
MD
Charles
“Hospital-based chemotherapy infusion billing must contain detailed clinical documentation to support the complexity of care provided, yet many billing companies submit inpatient claims without verifying that the infusion records and oncologist notes justify the service level. Our billing had high-acuity infusion claims denied until Credex began reviewing all hospital and extended session infusion documentation before submission.”
CFO
Perla
“Managing oncology billing across six units meant certification and prior-authorization tracking systems operating across these units in isolation, and a fragmented standard for chemotherapy and infusion revenue optimization. Credex standardized our billing processes, implemented a unified reporting dashboard showing chemotherapy, infusion, and J-code revenue by payer for each site, and compliance consistency improved across all locations. Our quarterly financial reviews now present the most accurate and audit-ready data we’ve ever had.”
Agency Assessment
We audit your current oncology billing workflow, chemotherapy and infusion reconciliation process, prior authorization tracking workflow, CPT and J-codes assignment standards, A/R aging by payer, and denial history by reason code. This identifies pain points in chemotherapy/infusion billing and coding.
Provider Enrollment Verification
The establishment of authorizations begins with the correspondence of these forms with the applicable patient schedule and session plotting with reference to a renewal calendar to ensure full approval from government and commercial payers.
Oncology Documentation Setup
Our oncology billing specialists ensure clean claim submission by reviewing the following claim elements: chemotherapy and infusion documentation workflows. Submission of e-claims to various carriers, Medicare, and Medicaid follows after these elements are thoroughly reviewed against applicable standards.
Clean Claim Submission
We verify each patient’s certifications and prior authorizations, ensure all chemotherapy and infusion CPT codes and J-codes are fully accounted for, and check that finalized infusion documentation corresponds with billed services.
Denial Management & Follow-Up
Every claim is tracked through adjudication. Within 48 hours, denials are looked over again. Disputes about allergy test counts, changes to immunotherapy code combinations, and requests for biologic step treatment all get a specific answer based on the patient's medical record and the payer's rules.
Reporting & Ongoing Optimization
Each month, reports are generated showing how much money was collected by service type and customer, how well allergy tests were billed, how well immunotherapy injections worked, how much money was made from biotech drugs, how long it took to bill for immunology services, and how old the accounts receivable were. At the charge-capture level, recurring mistakes are fixed.
Credex Healthcare is a company like no other among various billing companies in the U.S., thanks to our expertise and experience in oncology billing, coupled with our industry knowledge that allows our workflows to adjust amid the changing regulations and standards in oncology billing. Our team, which comprises billers and coders, faces hundreds of oncology claims daily, and we are experts in requirements in the oncology insurance billing process, modern chemotherapy and infusion CPT code assignment standards, J-code drug billing, and payer-specific authorization workflows, aiming to protect your revenue from loss.
Our team is trained specifically in the oncology billing process. We do not treat oncology as a related specialty to general medicine. The coding rules, authorization workflows, and documentation standards for this specialty are distinct, and we know them in detail.
A Credex Healthcare-affiliated oncology billing expert understands your practice needs, pertinent requirements, and the very process that will secure your financial success despite market uncertainties.
Transparency lies at the core of our oncology billing service at Credex Healthcare. Our dedicated dashboard provides live updates on metrics, such as claim status, denial rates, A/R uptick, and collection rates, to promote real-time reporting.
By meeting all HIPAA requirements, our workflow ensures that strict security measures and patient data protection are maintained at all times.
Credex Healthcare understands that expecting the swift processing of your billing reimbursement is the bare minimum. We ensure that this happens all the time, while ensuring that your oncology practice grows in revenue and financial performance by leveraging our decade-long experience and expertise in oncology billing.
Lying at the core of our medical billing operations is our team of experts who share the same expertise that we cultivated, so you can enjoy complete payments for your oncology services, such as chemotherapy and infusion drugs, through our clean claim submissions, hassle-free revenue inflows, and first-pass insurance claims.
Oncology billing services are elements relevant to the everyday operation of an oncology practice. From filing and submission of claims to addressing denials, it is part of the mechanism of a functioning healthcare facility. Without support from specialized oncology billing services, practices are vulnerable to claim denials, delayed reimbursement, and noncompliance with the prevailing billing standards.
CPT codes 96365–96417 are the most used codes for oncology billing. These codes must specify the procedures involved, and a modifier must be accurately set. Key CPT codes for cardiovascular procedures include 96413 (initial hour of chemotherapy infusion), 96415 (each additional hour), 96417 (IV push), and 96365 (initial hour of non-chemotherapy infusion).
Yes. Insurance covers oncology-related services and procedures. However, coverage is subject to review of factors such as the provider, state, and specific treatment plan. Additionally, infusion drug administration and specialized cancer treatments are considered carefully due to their medical-necessity criteria.
E-claims for oncology billing are paid within 14 to 30 days, but a longer 30 to 60 days can be expected when processed in-house. It is important to consider the timeline when submitting clean claims, as well as the medium of transmission, as electronic submissions are processed faster than traditional submissions.
The billing industry is rapidly evolving. By the year 2025, the system and tools used
Billing companies ensure compliance with HIPAA and other regulations by being legitimate and reliable. Every
At Credex Healthcare, we know how frustrating it is when claims are denied. That is
Fill the form and someone from our team will get back to you. Or you can also call us on (833) 477-1261.
